the aid library

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021
recommended

World Health Organization WHO (2021) C_WHO

Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-... more

Download (186)

View PDF (223)

Prévention et traitement de l'infection à VIH et des autres infections sexuellement transmissibles chez les hommes ayant des rapports sexuels avec d'autres hommes et chez les personnes transgenres

Organisation mondiale de la Santé (World Health Organization); UNAIDS; UNDP; et al. (2011) C_WHO

Recommandations pour une approche de santé publique Programme VIH/SIDA

Download (399)

View PDF (180)

Optimal feeding of low birts weight infants

Neonatal Guideline Development Group, Ministry of Health & Family Welfare, India (2017) C1

Standard Treatment Guidelines

Download (214)

View PDF (251)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (147)

View PDF (211)

Practice Education in Nursing

Registered Nurses’ Association of Ontario (RNAO) (2016) CC

The purpose of this Guideline is to provide evidence-based recommendations that promote and sustain the undergraduate nursing student’s application of knowledge to practice in a variety of clinical learning environments. The Guideline explores the relationships among and between students and nursi... more

External Link

Medical Ethics and Bedside Rationing in Low‐Income Countries: Challenges and Opportunities

Kapiriri, L. ResearchGate (2017) CC

Bioethics - Medical, Ethical and Legal Perspectives There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas.... more

Download (214)

View PDF (255)

Directives sur le pouvoir de prescription des infirmières 2021

Stewart, D., Schober, M., Nissen, L. et al. Conseil International des Infirmières (2021) CC

Ces orientations relatives à la prescription par les infirmières sont destinées à aider les infirmières, les équipes, les associations, les organisations, les enseignants, les organismes de réglementation et les gouvernements du monde entier. Les nations et les régions peuvent évaluer les b... more

Download (239)

View PDF (241)

Preparing for and responding to global health emergencies

Cochrane Convenes (2022) C1

Learnings from the COVID-19 evidence response and recommendations for the future. Reflections and recommendations from the evidence synthesis community.

Download (176)

View PDF (41)

Protocolo Clínico e Diretrizes Terapêuticas Doença de Chagas

Ministério da Saúde, Brazil (2018) CC

Outubro/2018 Nº 397

Download (442)

View PDF (418)

Linges directrices unifiées sur l'utilisation des Antirétroviraux pour le traitement et la prévention de l'infection à VIH

Organisation mondiale de la Santé (2013) C_WHO

Recommandations pour une Approche de Santé publique. Juin 2013.

Download (140)

View PDF (185)

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19 : 2 DE MARÇO DE 2021

Organização Mundial da Saúde (OMS) OPAS (2021) C_WHO

Resumo: o que é esta orientação dinâmica? Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19? Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde. Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ... more

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021 recommended

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021
recommended